🇺🇸 Perdipine injection in United States

5 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 5

Most-reported reactions

1. Abdominal Pain — 1 report (20%)
2. Feeding Disorder — 1 report (20%)
3. Ileus — 1 report (20%)
4. Nausea — 1 report (20%)
5. Renal Impairment — 1 report (20%)

Source database →

Frequently asked questions

Is Perdipine injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Perdipine injection in United States?

Astellas Pharma China, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.